1. Home
  2. Medical Research
  3. Seattle, WA
  4. Altius Institute for Biomedical Sciences

Altius Institute for Biomedical Sciences

Altius Institute for Biomedical Sciences has an America's Best Score of 30 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Seattle, WA
  • Tax-exempt since 2017
  • EIN: 47-2231080
altiusinstitute.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
30OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Altius Institute for Biomedical Sciences is a 501(c)(3) organization, classified under Medical Research (NTEE H20). Contributions are tax-deductible.

2211 Elliott Ave Ste 600, Seattle, WA 98121-3626

Among the 17 scored medical research organizations in Seattle, Altius Institute for Biomedical Sciences holds 2.8 months of operating reserves (peer median 5.5 months), runs a typical yearly deficit of 16.4% (peers: surplus of 1.3%), and has cut spending 20.4% a year (peers: grown spending 3.8% a year).

In fiscal year 2025 it reported $24,030,198 in revenue and $27,278,501 in expenses, with contributions making up 98.9% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The mission of the Altius Institute for Biomedical Sciences (altius) is to advance the science of gene regulation for the benefit of human health.

Main program · fiscal year 2025

  • Altius directly conducts an active and multifaceted program of basic biomedical research in the fields of genetics, genomics, epigenetics and biotechnology. We conduct the majority of research programs directly in our own laboratories located in Seattle, Washington, and also collaborate with academic research hospitals. Altius aims to discover, develop, and translate for clinical use both data and… Read more

    Altius directly conducts an active and multifaceted program of basic biomedical research in the fields of genetics, genomics, epigenetics and biotechnology. We conduct the majority of research programs directly in our own laboratories located in Seattle, Washington, and also collaborate with academic research hospitals. Altius aims to discover, develop, and translate for clinical use both data and technologies that illuminate or enable the control of human genes in medically important biological contexts.

    $21,937,702 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 80¢ went to programs, 20¢ to management and 0¢ to fundraising.

  • Programs $21,937,702
  • Management $5,340,799
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score30 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves2.8 mo; 2.4 mo in cash2 / 25
Financial balance (median margin)−16.4%4.1 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth−20.4% / yr0 / 15
Track record9 years3.6 / 10
Debt load57.3% of assets0.6 / 10
Total30.2 → 30
Spending on programs
Not scored; America's Best needs 65%+
80%Meets

Compared with Seattle peers

MeasureThis organizationPeer median
Operating reserves2.8 mo5.5 mo
Typical margin−16.4%+1.3%
Spending growth−20.4% / yr+3.8% / yr
Debt load57.3%25.3%

Peers: the 17 Seattle medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$24,030,198Fiscal year 20252022: $55,346,56520222023: $25,796,65920232024: $25,521,01820242025: $24,030,1982025
Expenses$27,278,501Fiscal year 20252022: $54,165,33220222023: $35,992,83120232024: $32,275,65720242025: $27,278,5012025
Total assets$14,930,959Fiscal year 20252022: $39,729,55920222023: $26,636,89820232024: $17,386,20620242025: $14,930,9592025
Total liabilities$8,547,957Fiscal year 20252022: $13,226,15820222023: $10,250,95420232024: $7,754,90120242025: $8,547,9572025
Fiscal year ending December 2025
Revenue$24,030,198
Expenses$27,278,501
Net income−$3,248,303
Net assets$6,383,002

Notable sources of revenue

Percent of total revenue
Contributions$23,759,928
Program services$0
Investment income$194,163
Other (net)$76,107

Assets / debt

Total assets$14,930,959
Total liabilities$8,547,957
Net assets$6,383,002

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$25,521,018
Expenses$32,275,657
Net income−$6,754,639
Net assets$9,631,305

Notable sources of revenue

Percent of total revenue
Contributions$25,653,464
Program services$0
Investment income−$192,408
Other (net)$59,962

Assets / debt

Total assets$17,386,206
Total liabilities$7,754,901
Net assets$9,631,305

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$25,796,659
Expenses$35,992,831
Net income−$10,196,172
Net assets$16,385,944

Notable sources of revenue

Percent of total revenue
Contributions$25,808,096
Program services$189,574
Investment income−$275,420
Other (net)$74,409

Assets / debt

Total assets$26,636,898
Total liabilities$10,250,954
Net assets$16,385,944

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$55,346,565
Expenses$54,165,332
Net income$1,181,233
Net assets$26,503,401

Notable sources of revenue

Percent of total revenue
Contributions$42,586,134
Program services$12,797,574
Investment income$69,795
Other (net)−$106,938

Assets / debt

Total assets$39,729,559
Total liabilities$13,226,158
Net assets$26,503,401

Compensation

Officers and key employees$1,360,485
Share of expenses2.5%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?